KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Guardant Health (GH) Interest Expenses (2017 - 2026)

Guardant Health's Interest Expenses history spans 9 years, with the latest figure at $1.2 million for Q4 2025.

  • On a quarterly basis, Interest Expenses rose 82.95% to $1.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.9 million, a 50.99% increase, with the full-year FY2025 number at $3.9 million, up 50.99% from a year prior.
  • Interest Expenses hit $1.2 million in Q4 2025 for Guardant Health, up from $943000.0 in the prior quarter.
  • Over the last five years, Interest Expenses for GH hit a ceiling of $1.2 million in Q4 2025 and a floor of $643000.0 in Q4 2021.
  • Historically, Interest Expenses has averaged $710500.0 across 5 years, with a median of $645000.0 in 2022.
  • The widest YoY moves for Interest Expenses: up 7950.0% in 2021, down 86.42% in 2021.
  • Tracing GH's Interest Expenses over 5 years: stood at $643000.0 in 2021, then rose by 0.16% to $644000.0 in 2022, then grew by 0.16% to $645000.0 in 2023, then changed by 0.0% to $645000.0 in 2024, then skyrocketed by 82.95% to $1.2 million in 2025.
  • Business Quant data shows Interest Expenses for GH at $1.2 million in Q4 2025, $943000.0 in Q3 2025, and $983000.0 in Q2 2025.